Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Industry Supported Education
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Young children are at increased risk of becoming seriously ill with pneumonia - but unlike in years past, the cause is usually a respiratory virus.
Meda announced that the Food and Drug Administration (FDA) has approved Dymista (azelastine HCl and fluticasone propionate) for the relief of symptoms of seasonal allergic rhinitis (SAR) in patients ages 6-11 who require treatment with both components.
The Food and Drug Administration (FDA) has accepted for Priority Review a supplemental New Drug Application (sNDA) for Rapamune (sirolimus; Pfizer) for the treatment of lymphangioleiomyomatosis (LAM).
Snoring can be indicative of increased upper airway resistance, a symptom of chronic sleep apnea, or associated with comorbidities such as obesity and hypothyroidism; it can also occur in the absence of any of these conditions (primary snoring).
Featured courses from mycme
In this activity, experts will review the role of inflammation in both the large and ...
This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...